Patients who underwent a gastric bypass and develop a irondeficiency postoperatively. The medical condition which is investigated is irondeficiency
Conditions
Sponsors
Rijnstate Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients who underwent a gastric bypass and develop a irondeficiency postoperatively. (ferritin=65 years) no F.1.3.1 Number of subjects for this age range 0
Exclusion criteria
Exclusion criteria: iron deficiency preoperative, bloodtransfusios during studyperiod, ironcontaining nutritional supplements except the 'standard' multivitamins after bariatric surgery, decreased renal failure, excessive menstruational blood loss, anemia not caused by irondeficiency, accumulation of iron, hypersensitivity for one of the medicinal products, psychiatric illness, pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Evaluation of the optimal treatment for an irondeficiency after a gastric bypass (roux-en-y gastric bypass). ;Secondary Objective: What is the effective time of Ferinject Evaluate the patient's preference for either oral treatment or intravenous treatment;Primary end point(s): normal value serum ferritin;Timepoint(s) of evaluation of this end point: 6 , 12, 26 en 52 weeks after starting therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): enquetes with the preference for oral or intraveneus ironsuppletion.;Timepoint(s) of evaluation of this end point: 6 , 12, 26 en 52 weeks after starting therapy | — |
Countries
Netherlands
Contacts
Public ContactWendy Schijns
Rijnstate hospital
Outcome results
None listed